JP2024519614A5 - - Google Patents
Info
- Publication number
- JP2024519614A5 JP2024519614A5 JP2023568236A JP2023568236A JP2024519614A5 JP 2024519614 A5 JP2024519614 A5 JP 2024519614A5 JP 2023568236 A JP2023568236 A JP 2023568236A JP 2023568236 A JP2023568236 A JP 2023568236A JP 2024519614 A5 JP2024519614 A5 JP 2024519614A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- nucleic acid
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21172722.7 | 2021-05-07 | ||
| EP21172722 | 2021-05-07 | ||
| PCT/EP2022/062338 WO2022234116A1 (en) | 2021-05-07 | 2022-05-06 | Combination of prame specific t cell receptors and chimeric co-stimulatory receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519614A JP2024519614A (ja) | 2024-05-20 |
| JP2024519614A5 true JP2024519614A5 (enExample) | 2025-05-14 |
Family
ID=75870458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568236A Pending JP2024519614A (ja) | 2021-05-07 | 2022-05-06 | Ｐｒａｍｅ特異的ｔ細胞受容体とキメラ補助刺激受容体との組合せ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240277762A1 (enExample) |
| EP (1) | EP4334331A1 (enExample) |
| JP (1) | JP2024519614A (enExample) |
| KR (1) | KR20240005865A (enExample) |
| CN (1) | CN117279931A (enExample) |
| AU (1) | AU2022270947A1 (enExample) |
| CA (1) | CA3215758A1 (enExample) |
| WO (1) | WO2022234116A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250133715A (ko) | 2023-01-06 | 2025-09-08 | 이뮤노코어 리미티드 | Prame 펩타이드-hla 복합체에 대한 결합 분자 |
| WO2025219541A1 (en) * | 2024-04-19 | 2025-10-23 | Medigene Immunotherapies Gmbh | Constant uni-tabs |
| EP4635976A1 (en) * | 2024-04-19 | 2025-10-22 | Medigene Immunotherapies GmbH | Constant uni-tabs |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4703004A (en) | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
| US4851341A (en) | 1986-12-19 | 1989-07-25 | Immunex Corporation | Immunoaffinity purification system |
| EP2006376A1 (en) | 2007-06-21 | 2008-12-24 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH | Fusion protein comprising a caspase domain and a nuclear hormone receptor binding domain and methods and uses thereof |
| CN103965361B (zh) * | 2013-02-06 | 2018-10-30 | 上海细胞治疗工程技术研究中心集团有限公司 | 一种t细胞信号的嵌合分子转换器及其用途 |
| AU2016230828B2 (en) * | 2015-03-10 | 2020-10-22 | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) | T-cell receptors directed against the preferentially expressed antigen of melanoma and uses thereof |
| JP6989138B2 (ja) * | 2016-06-17 | 2022-01-05 | メディジーン イミュノテラピーズ ゲーエムベーハー | Ｔ細胞受容体及びその使用 |
| WO2018119198A1 (en) * | 2016-12-22 | 2018-06-28 | Windmil Therapeutics, Inc. | Compositions and methods for modulating the immune system |
| GB201709866D0 (en) * | 2017-06-20 | 2017-08-02 | Immunocore Ltd | T cell receptors |
| US11738047B2 (en) * | 2017-12-12 | 2023-08-29 | The Trustees Of The University Of Pennsylvania | Genetically modified immune cells targeting NY-ESO-1 and methods of use thereof |
| AU2018395397A1 (en) * | 2017-12-28 | 2020-08-06 | Gritstone Bio, Inc. | Antigen-binding proteins targeting shared antigens |
| CN108794619B (zh) * | 2018-05-31 | 2021-09-17 | 郑州大学 | 一种高亲和pd-1蛋白突变体 |
| CU20220029A7 (es) * | 2019-11-18 | 2023-01-16 | BioNTech SE | Receptores de tcr de prame |
-
2022
- 2022-05-06 CN CN202280033681.4A patent/CN117279931A/zh active Pending
- 2022-05-06 KR KR1020237041837A patent/KR20240005865A/ko active Pending
- 2022-05-06 CA CA3215758A patent/CA3215758A1/en active Pending
- 2022-05-06 WO PCT/EP2022/062338 patent/WO2022234116A1/en not_active Ceased
- 2022-05-06 US US18/289,801 patent/US20240277762A1/en active Pending
- 2022-05-06 EP EP22727928.8A patent/EP4334331A1/en active Pending
- 2022-05-06 JP JP2023568236A patent/JP2024519614A/ja active Pending
- 2022-05-06 AU AU2022270947A patent/AU2022270947A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022502056A5 (enExample) | ||
| ES2734190T3 (es) | Receptores de linfocitos T | |
| JP2023139070A5 (enExample) | ||
| JP7346294B2 (ja) | 対合が改善されたｔ細胞受容体ｔ細胞 | |
| ES2904301T3 (es) | Receptores de células T dirigidos contra Bob1 y usos de los mismos | |
| JP2022109953A5 (enExample) | ||
| JP2018532407A5 (enExample) | ||
| JP2020114264A5 (enExample) | ||
| JP2021520198A5 (enExample) | ||
| JP2025060882A5 (enExample) | ||
| JP7288503B2 (ja) | 改変された抗ｃｄ１９ ｃａｒ－ｔ細胞 | |
| JP2017537627A5 (enExample) | ||
| JP2018531014A5 (enExample) | ||
| JP2020537515A5 (enExample) | ||
| CA3198447A1 (en) | Combination therapies with chimeric antigen receptor (car)-expressing cells | |
| JP2016520074A5 (enExample) | ||
| JP2021526795A5 (enExample) | ||
| JP2019513394A5 (enExample) | ||
| CN107001443A (zh) | T细胞受体 | |
| CN105209065A (zh) | 控制t细胞增殖的方法 | |
| JP2023500338A5 (enExample) | ||
| JP2021531834A5 (enExample) | ||
| JP2023539591A5 (enExample) | ||
| JP2022521240A5 (enExample) | ||
| JP2022533092A5 (enExample) |